Drug intelligence / Profile preview

[99mTc]Tc-Soluplus + glucose

Development stage
Preclinical
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

[99mTc]Tc-Soluplus + glucose is a radiopharmaceutical imaging agent (radionanoprobe) developed for preclinical oncology research. It consists of Soluplus® polymeric micelles functionalized with glucose to target the GLUT1 transporter, which is frequently overexpressed in tumor cells. The micelles are radiolabeled with technetium-99m (99mTc) for detection via Single-Photon Emission Computed Tomography (SPECT). This diagnostic tool is primarily used to characterize biological processes, diagnose, and monitor therapeutic interventions in animal models of breast and colon cancer. The nanoprobe maintains a size of approximately 100 nm and has demonstrated effective signal-to-background ratios in breast cancer models.

Other names
[99mTc]Tc-Soluplus-glucose99mTc-labeled glucose-functionalized Soluplus micelles
02

Targets

GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on [99mTc]Tc-Soluplus + glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [99mTc]Tc-Soluplus + glucose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call